UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 90 filers reported holding UTAH MED PRODS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $423,308 | -6.0% | 6,336 | 0.0% | 0.04% | 0.0% |
Q1 2024 | $450,553 | -15.6% | 6,336 | 0.0% | 0.04% | -18.5% |
Q4 2023 | $533,618 | -33.6% | 6,336 | -32.1% | 0.05% | -42.6% |
Q3 2023 | $803,068 | -7.7% | 9,338 | 0.0% | 0.09% | -3.1% |
Q2 2023 | $870,302 | -5.4% | 9,338 | -3.8% | 0.10% | -13.4% |
Q1 2023 | $920,217 | -5.7% | 9,710 | 0.0% | 0.11% | -9.7% |
Q4 2022 | $976,146 | +17.9% | 9,710 | 0.0% | 0.12% | -12.7% |
Q3 2022 | $828,000 | -0.7% | 9,710 | 0.0% | 0.14% | -30.0% |
Q2 2022 | $834,000 | -4.5% | 9,710 | 0.0% | 0.20% | +14.7% |
Q1 2022 | $873,000 | -55.0% | 9,710 | -50.0% | 0.18% | -11.1% |
Q4 2021 | $1,942,000 | +230.3% | 19,420 | +206.5% | 0.20% | +55.5% |
Q3 2021 | $588,000 | +9.1% | 6,336 | 0.0% | 0.13% | +32.0% |
Q2 2021 | $539,000 | -1.8% | 6,336 | 0.0% | 0.10% | -3.0% |
Q1 2021 | $549,000 | +2.8% | 6,336 | 0.0% | 0.10% | -12.3% |
Q4 2020 | $534,000 | +5.5% | 6,336 | 0.0% | 0.11% | -14.9% |
Q3 2020 | $506,000 | +1.8% | 6,336 | +13.0% | 0.13% | +6.3% |
Q2 2020 | $497,000 | – | 5,605 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nine Ten Partners LP | 271,139 | $16,282,000 | 5.30% |
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC | 188,732 | $11,333,000 | 2.93% |
Opus Capital Group, LLC | 36,877 | $2,214,000 | 0.32% |
Clean Yield Group | 8,581 | $515,000 | 0.23% |
Ativo Capital Management LLC | 7,372 | $443,000 | 0.18% |
Ancora Advisors LLC | 22,009 | $1,322,000 | 0.16% |
Penobscot Investment Management Company, Inc. | 6,000 | $360,000 | 0.11% |
Wallace Capital Management Inc. | 9,010 | $541,000 | 0.10% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 36,300 | $2,180,000 | 0.05% |
CONNORS INVESTOR SERVICES INC | 3,591 | $216,000 | 0.05% |